Erdem Taş
Erdem Taş has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Fatih Albayrak
Department of Rheumatology, Gaziantep University, 27310 Gaziantep, Turkey
1 shared publication - Hüseyin Çolak
Internal Medicine Department, Gaziantep University Hospital Faculty of Medicine, Gaziantep, Türkiye
1 shared publication - Orhan Zengin
Department of Rheumatology, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye
1 shared publication - Pınar Korkmaz
Dermatology Department, Gaziantep University Hospital Faculty of Medicine, Gaziantep, Türkiye
1 shared publication - Reha Baran
Department of Rheumatology, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye
1 shared publication
Latest Publications
- Open Access
- 15 June 2026
- Published by Caleo in Rheumatology Quarterly
- Vol. 4 (2) , 128-132
Granulomatous Mastitis, Erythema Nodosum, and Arthritis Syndrome: Case Presentation and Literature Review
Granulomatous mastitis (GM) is an inflammatory breast disease that may rarely be accompanied by systemic manifestations such as erythema nodosum (EN) and arthritis. In recent years, the association of GM with EN, with or without arthritis, has been recognized as GMENA syndrome. This report presents a case of GMENA syndrome and reviews the published literature. A 26-year-old woman presented with swelling, erythema, pain, and discharge in the left breast. Initial evaluation suggested infectious mastitis, but prolonged antibiotic therapy was ineffective. During follow-up, bilateral ankle arthritis and pretibial EN developed. Laboratory tests showed marked systemic inflammation. Core needle biopsy demonstrated chronic granulomatous inflammation, and microbiological studies were negative. The GMENA syndrome was diagnosed after exclusion of alternative causes. Methylprednisolone led to rapid improvement in both breast and systemic manifestations. A review of published cases showed a similar pattern of unilateral breast involvement, EN, and frequent peripheral arthritis or arthralgia, with generally favorable responses to corticosteroid therapy. Granulomatous mastitis should be considered in patients with treatment-resistant inflammatory breast lesions accompanied by systemic findings such as EN and arthritis. Recognition of this clinical pattern may help avoid unnecessary antibiotic use and allow timely initiation of appropriate immunosuppressive treatment.
- 15 June 2026
- Published by Caleo in Rheumatology Quarterly
- Vol. 4 (2) , 128-132
Open AccessGranulomatous Mastitis, Erythema Nodosum, and Arthritis Syndrome: Case Presentation and Literature Review
Granulomatous mastitis (GM) is an inflammatory breast disease that may rarely be accompanied by systemic manifestations such as erythema nodosum (EN) and arthritis. In recent years, the association of GM with EN, with or without arthritis, has been recognized as GMENA syndrome. This report presents a case of GMENA syndrome and reviews the published literature. A 26-year-old woman presented with swelling, erythema, pain, and discharge in the left breast. Initial evaluation suggested infectious mastitis, but prolonged antibiotic therapy was ineffective. During follow-up, bilateral ankle arthritis and pretibial EN developed. Laboratory tests showed marked systemic inflammation. Core needle biopsy demonstrated chronic granulomatous inflammation, and microbiological studies were negative. The GMENA syndrome was diagnosed after exclusion of alternative causes. Methylprednisolone led to rapid improvement in both breast and systemic manifestations. A review of published cases showed a similar pattern of unilateral breast involvement, EN, and frequent peripheral arthritis or arthralgia, with generally favorable responses to corticosteroid therapy. Granulomatous mastitis should be considered in patients with treatment-resistant inflammatory breast lesions accompanied by systemic findings such as EN and arthritis. Recognition of this clinical pattern may help avoid unnecessary antibiotic use and allow timely initiation of appropriate immunosuppressive treatment.